会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
    • 丙型肝炎病毒基因型,其用作预防,治疗和诊断剂
    • US07196183B2
    • 2007-03-27
    • US10230381
    • 2002-08-29
    • Erwin SablonLeen-Jan Van DoornWim Quint
    • Erwin SablonLeen-Jan Van DoornWim Quint
    • C07H21/04C12P19/34C12Q1/70
    • C12Q1/707
    • The present invention relates to genomic nucleotide sequences and amino acid sequences corresponding to the non-coding and coding region of a new type of HCV. The invention relates to new HCV types and subtypes sequences which are different from the known HCV types and subtypes sequences. Particularly, the present invention relates to said new HCV type sequences; a process for preparing them, and their use for diagnosis, prophylaxis and therapy. More particularly, the present invention provides new type-specific sequences of the 5′ NCR, Core, the E1 and the NS5 regions of the new HCV type. These new HCV sequences are useful to diagnose the presence of HCV type genotypes or serotypes in a biological sample. Moreover, the availability of these new type-specific sequences can increase the overall sensitivity of HCV detection and should also prove to be useful for prophylactic and therapeutic purposes.
    • 本发明涉及对应于新型HCV的非编码区和编码区的基因组核苷酸序列和氨基酸序列。 本发明涉及与已知的HCV类型和亚型序列不同的新的HCV类型和亚型序列。 特别地,本发明涉及所述新型HCV型序列; 它们的制备过程及其在诊断,预防和治疗中的应用。 更具体地说,本发明提供新HCV型5'NCR,核心,E1和NS5区域的新型特异性序列。 这些新的HCV序列可用于诊断生物样品中HCV型基因型或血清型的存在。 此外,这些新型特异性序列的可用性可以提高HCV检测的总体灵敏度,并且还应证明可用于预防和治疗目的。